Abstract
Amphotericin B (Amb) is a broad-spectrum polyene macrolide antibiotic which has been a drug of choice for fatal conditions like fungal splenic abscess. Hence a drug delivery system with splenotropic potencial might be of great significance for further therapeutic effectiveness. Present manuscript proposes development of Irregular shaped polymer lipid hybrid nanostructures (LIPOMER) of Amb with enhanced splenic uptake. Amb LIPOMER (~400 nm) was prepared using poly(methylvinylether-co-maleic anhydride) [Gantrez® AN119] and glyceryl monosterarate (GMS) as matrix material. Conditions for preparation of formulation were optimized using 23 factorial design and effect of the concentration of excipients on the particle size and entrapment efficiency was evaluated. Optimized formulation was further characterized using Transmission electron microscopy (TEM), X-ray diffraction (XRD), differential scanning calorimetry (DSC) and Fourier transformed infrared spectroscopy (FTIR) techniques. Amb LIPOMER exhibited acceptable haemolysis when assessed for In-vitro hemolytic potential in comparison to Fungisome TM. The high splenic uptake of Amb LIPOMER was verified using gamma scintigraphic technique in small animal model. Results of our study indicated that LIPOMER system can be a smart drug delivery platform for Amb to eradicate splenic infections effectively.
Keywords: Amphotericin B, enhanced splenic uptake, LIPOMER, nano-system, scintigraphy, splenic abscess.
Drug Delivery Letters
Title:Amphotericin B LIPOMER for Enhanced Splenic Delivery
Volume: 4 Issue: 3
Author(s): Kalpa S. Nagarsekar, Chandrakant N. Galdhar, Rajiv V. Gaikwad, Abdul Samad and Padma V. Devarajan
Affiliation:
Keywords: Amphotericin B, enhanced splenic uptake, LIPOMER, nano-system, scintigraphy, splenic abscess.
Abstract: Amphotericin B (Amb) is a broad-spectrum polyene macrolide antibiotic which has been a drug of choice for fatal conditions like fungal splenic abscess. Hence a drug delivery system with splenotropic potencial might be of great significance for further therapeutic effectiveness. Present manuscript proposes development of Irregular shaped polymer lipid hybrid nanostructures (LIPOMER) of Amb with enhanced splenic uptake. Amb LIPOMER (~400 nm) was prepared using poly(methylvinylether-co-maleic anhydride) [Gantrez® AN119] and glyceryl monosterarate (GMS) as matrix material. Conditions for preparation of formulation were optimized using 23 factorial design and effect of the concentration of excipients on the particle size and entrapment efficiency was evaluated. Optimized formulation was further characterized using Transmission electron microscopy (TEM), X-ray diffraction (XRD), differential scanning calorimetry (DSC) and Fourier transformed infrared spectroscopy (FTIR) techniques. Amb LIPOMER exhibited acceptable haemolysis when assessed for In-vitro hemolytic potential in comparison to Fungisome TM. The high splenic uptake of Amb LIPOMER was verified using gamma scintigraphic technique in small animal model. Results of our study indicated that LIPOMER system can be a smart drug delivery platform for Amb to eradicate splenic infections effectively.
Export Options
About this article
Cite this article as:
Nagarsekar Kalpa S., N. Galdhar Chandrakant, V. Gaikwad Rajiv, Samad Abdul and V. Devarajan Padma, Amphotericin B LIPOMER for Enhanced Splenic Delivery, Drug Delivery Letters 2014; 4 (3) . https://dx.doi.org/10.2174/2210303104666140807232823
DOI https://dx.doi.org/10.2174/2210303104666140807232823 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
First Report on the Characteristics of Methicillin-Resistant <i>Staphylococcus Capitis</i> Isolates and an NRCS-A-clone Related Isolate Obtained from Iranian Children
Infectious Disorders - Drug Targets Hypereosinophilic Syndrome, Churg-Strauss Syndrome and Parasitic Diseases: Possible Links between Eosinophilia and Thrombosis
Current Vascular Pharmacology ARC - Augmented Renal Clearance
Current Pharmaceutical Biotechnology The Escalating Challenge of Vancomycin Resistance in Staphylococcus aureus
Current Drug Targets - Infectious Disorders Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms
Current Topics in Medicinal Chemistry Anti-MRSA Cephems: An Update
Current Medicinal Chemistry - Anti-Infective Agents An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome
Infectious Disorders - Drug Targets Complications of Infective Endocarditis
Cardiovascular & Hematological Disorders-Drug Targets The Adult Patient with Eisenmenger Syndrome: A Medical Update After Dana Point Part I: Epidemiology, Clinical Aspects and Diagnostic Options
Current Cardiology Reviews In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets
Infectious Disorders - Drug Targets Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
Current Cardiology Reviews Concurrent Methicillin-Resistant <i>Staphylococcus aureus Septicemia</i> and Thyroid Abscess in a Young Male with Dengue
Infectious Disorders - Drug Targets Nanomedical Strategies for Targeting Skin Microbiomes
Current Drug Metabolism Can Infectious Biofilm be Controlled by Blocking Bacterial Communication?
Medicinal Chemistry Disseminated TB in an Immunocompetent Patient: A Case Report
Infectious Disorders - Drug Targets Ruptured Multiple Mycotic Aneurysms Following Infective Endocarditis: Effectiveness of Catheter-based Techniques Using N-butyl Cyanoacrylate in a Hemorrhage-induced Coagulopathy
Current Medical Imaging The Perils, Pitfalls and Opportunities of Using High Sensitivity Cardiac Troponin
Current Medicinal Chemistry Current Status of Imaging Infections with Radiolabeled Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry New Developments in Antimicrobial Use in Sepsis
Current Pharmaceutical Design Comparative Biochemistry of GH3, GH20 and GH84 β-N-acetyl-Dhexosaminidases and Recent Progress in Selective Inhibitor Discovery
Current Drug Targets